BRL-50481. BRL-50481 is a selective phosphodiesterase 7 (PDE7) inhibitor. In the presence of BRL-50481 the activity of hrPDE7A1 was inhibited against the phosphodiesterase (PDE3) and (PDE4). Studies have suggested a potential role of BRL-50481 in the treatment of osteoporosis.